Evidence map›Paper›PMID 27481054›Full record

ArticleThe American journal of tropical medicine and hygiene2016

Longevity of Genotype-Specific Immune Responses to Plasmodium falciparum Merozoite Surface Protein 1 in Kenyan Children from Regions of Different Malaria Transmission Intensity.

Natalie M Bowman, Jonathan J Juliano, Cynthia J Snider, Oksana Kharabora, Steven R Meshnick, John Vulule, Chandy C John, Ann M Moormann

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Naturally Acquired Antibodies againstPathogens (Basel, Switzerland) · 2021
    Review
  3. Immunization with full-lengthNPJ vaccines · 2020
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Natalie M BowmanDivision of Infectious Diseases, University of North Carolina, School of Medicine, Chapel Hill, North Carolina.
Jonathan J JulianoDivision of Infectious Diseases, University of North Carolina, School of Medicine, Chapel Hill, North Carolina. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Curriculum in Genetics and Molecular Biology, University of North Carolina, Chapel Hill, North Carolina. jjuliano@med.unc.edu.
Cynthia J SniderDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Oksana KharaboraDivision of Infectious Diseases, University of North Carolina, School of Medicine, Chapel Hill, North Carolina.
Steven R MeshnickDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
John VululeCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Chandy C JohnRyan White Center for Pediatric Infectious Disease and Global Health, Indiana University, Indianapolis, Indiana.
Ann M MoormannProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts.
University of North Carolina at Chapel Hill · USIndiana University Health · USKenya Medical Research Institute · KEUniversity of Massachusetts Chan Medical School · US

Funding

UNC CLINICAL AND TRANSLATIONAL SCIENCE AWARD: BPCAUL1RR025747 · NCRR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUNGE, MARSCHALL S. · 2008 to 2011
$44.6M
INFECTIOUS DISEASE PATHOGENESIS TRAININGT32AI007151 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JULIANO, JONATHAN J · 1985 to 2024
$5.5M
Human immunity to MSP-1 in Western KenyaR01AI043906 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI KAZURA, JAMES WALTER · 2004 to 2008
$3.0M
T Cell Immunity in Endemic Burkitt LymphomaR01CA134051 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MOORMANN, ANN M · 2008 to 2012
$2.3M
Within Host Selection of P. falciparum Variants by Artemisinin Combination TherapR01AI089819 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JULIANO, JONATHAN J · 2010 to 2014
$1.9M
The pathogenesis of T. cruzi in HIV-infected persons in BoliviaK23AI113197 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BOWMAN, NATALIE MCCARTER · 2014 to 2018
$878k
Immunologic Studies of Endemic Burkitt's LymphomaK08AI051565 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI MOORMANN, ANN M · 2002 to 2006
$542k
NCI NIH HHS R01 CA134051NCRR NIH HHS UL1 RR025747NIAID NIH HHS K08 AI051565NIAID NIH HHS K23 AI113197NIAID NIH HHS R01 AI043906NIAID NIH HHS R01 AI089819NIAID NIH HHS T32 AI007151
6 · The paper itself

Abstract

Naturally acquired immunity to Plasmodium falciparum presents a changing landscape as malaria control programs and vaccine initiatives are implemented. Determining which immunologic indicators remain surrogates of past infection, as opposed to mediators of protection, led us to compare stability of immune responses across regions with divergent malaria transmission intensities. A repeat cross-sectional study of Kenyan children from a malaria-holoendemic area and an epidemic-prone area was used to examine longitudinal antibody and interferon-gamma (IFN-γ) responses to the 3D7 and FVO variants of merozoite surface protein 1 (MSP1). Antibodies to MSP1 were common in both study populations and did not significantly wane over a 21-month time period. IFN-γ responses were less frequent and rapidly disappeared in children after a prolonged period of no malaria transmission. Antibody and IFN-γ responses rarely correlated with each other; however, MSP1-specific IFN-γ response correlated with lack of concurrent P. falciparum parasitemia of the same genotype, though only statistically significantly in the malaria-holoendemic region (odds ratio = 0.31, 95% confidence interval = 0.12-0.84). This study affirms that antimalarial antibodies are informative for evaluation of history of malaria exposure within individuals, whereas cell-mediated immunity, though short lived under natural exposure conditions, might provide an assessment of recent infection and protection from parasitemia.

Indexed as

ChildFemaleGenotypeHumansImmunity, HumoralKenyaMalaria, FalciparumMaleMerozoite Surface Protein 1Plasmodium falciparumTime FactorsMerozoite Surface Protein 1

Identifiers

PMID27481054
PMCPMC5014263
OpenAlexW2490620476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.